Methods and compositions for activating VEGF-D and VEGF-C
AssigneeVegenics Limited
InventorsBradley McColl, Megan E. Baldwin, Steven Stacker, Marc Achen
Life of this patent
Estimating the term…
Abstract
Methods for activating endothelial growth factors VEGF-C or VEGF-D with plasmin, and methods of treatment comprising administering a phamarceutical compositions comprising plasmin. Also disclosed are methods for screening for inhibitors of activation of the growth factors by plasmin, and method of treatment by blocking activation of VEGF-C/D activation by plasmin. Further disclosed are methods for screening for other proteases that activate VEGF-C/D, and for inhibitors of such activation. The invention further includes inhibitors of plasmin activity and methods of treating patients in need thereof with said inhibitors.
Claims11
A method for activating at least one vascular endothelial growth factor selected from the group consisting of purified VEGF-C and purified VEGF-D, comprising treating said at least one vascular endothelial growth factor with a serine protease.
A method for activating at least one vascular endothelial growth factor selected from the group consisting of VEGF-C and VEGF-D, comprising treating said at least one vascular endothelial growth factor with a purified serine protease.
Dependencies are inferred from the claim text.